NEOCLONE
Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies.
NEOCLONE
Industry:
Biotechnology Health Care Medical
Founded:
1999-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.neoclone.com
Total Employee:
11+
Status:
Active
Contact:
(608) 260.8190
Total Funding:
1.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins PHP PHP 7
Similar Organizations
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Funding Round - Neoclone
National Institutes of Health
National Institutes of Health investment in Grant - Neoclone
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Angel Round - Neoclone
Silicon Pastures
Silicon Pastures investment in Angel Round - Neoclone
National Institutes of Health
National Institutes of Health investment in Grant - Neoclone
Official Site Inspections
http://www.neoclone.com
- Host name: neoclone.supranet.net
- IP address: 66.170.16.100
- Location: Portage United States
- Latitude: 43.55
- Longitude: -89.4738
- Metro Code: 669
- Timezone: America/Chicago
- Postal: 53901
More informations about "Neoclone"
NeoClone – Antibody Excellence
Let NeoClone help you develop monoclonal antibodies against your very challenging target. Do you need Llama VHH, human scFv or traditional mouse hybridomas? Give us a call, and we'll …See details»
Company – NeoClone
This change in direction is the foundation of what NeoClone is today - a company focused on developing high quality antibodies for sale as reagents and establishing partnerships and …See details»
Neoclone - Crunchbase Company Profile & Funding
Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the …See details»
NeoClone Company Profile 2024: Valuation, Funding & Investors
Developer of monoclonal antibodies intended for use in biotechnology and research applications.See details»
Staff – NeoClone
Deven McGlenn is CEO of NeoClone and has been involved with the company since inception in 1999 and full-time since April 2002. During his tenure he has grown the business to $7M+ in revenues, 15+ FTEs and raised over $2.5M in …See details»
Neoclone Company Profile - Office Locations, Competitors ... - Craft
Neoclone is a company that offers monoclonal antibodies for reagent, diagnostic, and therapeutic use. It generates monoclonals through traditional fusion technology and through the ABL-MYC …See details»
NEOCLONE BIOTECHNOLOGY INTERNATIONAL - VentureRadar
NeoClone specializes in the development of custom monoclonal antibodies tailored to challenging targets. Utilizing advanced techniques such as hybridoma and phage display, NeoClone offers …See details»
Neoclone - Contacts, Employees, Board Members, Advisors
Neoclone has 4 current employee profiles, including Director of Phage Technologies Mark Sullivan. Neoclone has 1 board member or advisor, Richard Burgess.See details»
Neoclone - Funding, Financials, Valuation & Investors - Crunchbase
Neoclone is a research-focused company with an emphasis on emerging antibody technologies.See details»
NeoClone - Products, Competitors, Financials, Employees, …
NeoClone primarily serves research and diagnostic clients in the biotechnology industry. It was founded in 1999 and is based in Madison, Washington. You're one click away from the most …See details»
Neoclone Biotechnology - LinkedIn
Neoclone Biotechnology | 165 followers on LinkedIn. NeoClone produces high-quality monoclonal antibody products for the biotechnology and research markets.See details»
Neoclone Locations - Contract Research Map
1202 Ann St Madison, WI, 53713 United States Neoclone provides custom antibody development, antibody products, epitope services, long-term cell line storage, ascites development, and …See details»
Neoclone - Crunchbase
Neoclone is a research-focused company with an emphasis on emerging antibody technologies.See details»
Process Information - NeoClone
NeoClone is the already the Midwest's premier custom antibody development company. But now we've added antibody phage display capabilities to help us develop the diverse and specific …See details»
NeoClone | Biotech Careers
Antibody discovery & development Business Areas: Antibodies. Biotech-Careers is funded in part by the National Science FoundationSee details»
NeoClone - Overview, News & Similar companies | ZoomInfo.com
View NeoClone (www.neoclone.com) location in Wisconsin, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Neoclone | Scientist.com
Neoclone provides custom antibody development, antibody products, epitope services, long-term cell line storage, ascites development, and antibody purification. If your organization has a …See details»
NeoAb Technology – NeoClone
To address this demand, NeoClone's scientist have employed various techniques including: alternate cell line immortalization, multiple mouse strains, genetic immunization, and different …See details»
NeuClone | Increasing Patient Access
Developing a diverse portfolio of clinically identical biosimilars for patients, globally. We value affordable access to healthcare, the quality and integrity of our science, and a strong patient …See details»
Resources – NeoClone
We're still making great monoclonal antibodies, of course! NeoClone has been making custom murine antibodies via hybridoma technology for years. In fact, that's where our catalog came …See details»